Brought to you by 
Aurora acquires Quorum Sciences
06 Nov 2000
Executive Summary
In a stock swap worth $5.2mm, Aurora Biosciences has acquired Quorum Sciences, a biotech that specializes mostly in biofilm inhibitors and antimicrobial target identification. The company paid with 81.2k of its common shares, which at the time sold at an average of $63.8 each.
Deal Industry
- Pharmaceuticals
-
Biotechnology
- Drug Discovery Tools
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Intra-Biotech Deal
- Payment Includes Stock
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Aurora acquires Quorum Sciences
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice